hcpcs_code stringlengths 5 5 | hcpcs_description stringlengths 10 256 | n_providers int64 1 498k | total_services int64 408k 102M | total_medicare_payment int64 11.8k 8.43B | avg_submitted_charge int64 0 9.01k |
|---|---|---|---|---|---|
91320 | Sarscv2 vac 30mcg trs-suc im | 36,800 | 4,506,697 | 663,520,364 | 163 |
82043 | Urine microalbumin (protein) level | 11,597 | 4,427,155 | 24,993,863 | 58 |
87086 | Bacterial colony count, urine | 4,506 | 4,406,190 | 34,813,358 | 51 |
99284 | Emergency department visit with moderate level of medical decision making | 65,448 | 4,389,227 | 374,843,174 | 795 |
97116 | Therapy procedure for walking training, each 15 minutes | 12,009 | 4,365,251 | 74,403,934 | 55 |
A0436 | Rotary wing air mileage, per statute mile | 348 | 4,291,202 | 131,395,606 | 357 |
J2357 | Injection, omalizumab, 5 mg | 617 | 3,851,801 | 113,422,267 | 84 |
90837 | Psychotherapy, 1 hour | 15,804 | 3,792,555 | 372,578,448 | 211 |
J7318 | Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | 1,475 | 3,779,716 | 19,209,975 | 31 |
J1437 | Injection, ferric derisomaltose, 10 mg | 969 | 3,751,157 | 59,095,356 | 66 |
Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 1,582 | 3,744,455 | 1,076,615 | 5 |
J7195 | Injection, factor ix (antihemophilic factor, recombinant) per iu, not otherwise specified | 2 | 3,739,916 | 5,269,023 | 3 |
J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 806 | 3,729,400 | 23,493,119 | 29 |
88341 | Special stained specimen slides to examine tissue, each additional procedure | 10,448 | 3,714,400 | 119,025,755 | 147 |
A0427 | Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) | 6,857 | 3,690,907 | 1,522,290,381 | 1,634 |
97535 | Training for self-care or home management, each 15 minutes | 17,873 | 3,689,997 | 72,561,916 | 63 |
Q5125 | Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram | 145 | 3,670,982 | 1,390,117 | 2 |
91322 | Sarscov2 vac 50 mcg/0.5ml im | 31,346 | 3,668,923 | 564,768,020 | 171 |
J7320 | Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg | 347 | 3,633,116 | 15,360,495 | 22 |
74177 | Ct scan of abdomen and pelvis with contrast | 23,893 | 3,593,132 | 287,212,665 | 613 |
67028 | Injection of drug into eye | 4,305 | 3,573,623 | 331,533,616 | 583 |
99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | 14,815 | 3,553,733 | 294,272,869 | 224 |
J2356 | Injection, tezepelumab-ekko, 1 mg | 206 | 3,539,998 | 49,939,375 | 42 |
83540 | Iron level | 8,692 | 3,526,157 | 22,309,606 | 33 |
90653 | Influenza vaccine, inactivated | 43,932 | 3,476,036 | 282,893,756 | 98 |
11102 | Biopsy of related skin growth, first growth | 19,666 | 3,452,445 | 206,752,898 | 225 |
83735 | Magnesium level | 7,154 | 3,435,068 | 22,513,816 | 38 |
92250 | Photography of the retina | 25,483 | 3,413,264 | 86,790,642 | 119 |
99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 44,310 | 3,401,229 | 125,911,678 | 118 |
82728 | Ferritin (blood protein) level | 8,894 | 3,396,801 | 45,282,197 | 79 |
98940 | Chiropractic manipulative treatment, 1-2 spinal regions | 11,909 | 3,370,055 | 62,816,386 | 49 |
85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | 7,224 | 3,287,573 | 20,807,456 | 32 |
J7187 | Injection, von willebrand factor complex (humate-p), per iu vwf:rco | 1 | 3,232,019 | 3,484,523 | 2 |
84153 | Psa (prostate specific antigen) measurement, total | 8,103 | 3,225,143 | 58,001,445 | 103 |
92012 | Established patient problem focused exam of visual system | 15,822 | 3,111,523 | 198,920,759 | 168 |
17110 | Destruction of skin growth, 1-14 growths | 20,550 | 3,076,352 | 226,537,539 | 243 |
J7325 | Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 1,653 | 3,066,514 | 21,151,093 | 33 |
J7336 | Capsaicin 8% patch, per square centimeter | 82 | 3,063,583 | 7,935,176 | 8 |
J7329 | Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg | 766 | 3,040,002 | 17,037,259 | 36 |
99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 10,926 | 2,958,539 | 106,566,352 | 97 |
87481 | Detection test for candida species (yeast), amplified probe technique | 1,217 | 2,935,874 | 99,973,379 | 60 |
A0428 | Ambulance service, basic life support, non-emergency transport, (bls) | 2,683 | 2,897,867 | 599,919,046 | 1,128 |
83550 | Iron binding capacity | 6,736 | 2,879,215 | 24,627,731 | 45 |
J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 593 | 2,848,101 | 101,026,285 | 128 |
77080 | Dxa bone density measurement of hip, pelvis, spine | 16,549 | 2,823,698 | 60,142,604 | 156 |
A0435 | Fixed wing air mileage, per statute mile | 89 | 2,819,231 | 32,904,745 | 139 |
J3304 | Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | 1,076 | 2,762,340 | 37,625,348 | 48 |
77014 | Ct guidance for insertion of radiation therapy fields | 4,401 | 2,745,231 | 153,845,243 | 304 |
87186 | Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution | 2,406 | 2,718,641 | 23,016,992 | 55 |
92133 | Imaging of optic nerve | 25,384 | 2,709,619 | 64,643,492 | 111 |
J9025 | Injection, azacitidine, 1 mg | 198 | 2,695,927 | 793,386 | 9 |
J0178 | Injection, aflibercept, 1 mg | 3,155 | 2,690,616 | 1,756,326,820 | 1,717 |
97150 | Therapy procedure in a group setting | 10,254 | 2,656,691 | 27,997,116 | 51 |
92083 | Exam of visual field with extended testing | 25,834 | 2,652,036 | 114,310,947 | 150 |
J0872 | Injection, daptomycin (xellia), unrefrigerated, not therapeutically equivalent to j0878 or j0873, 1 mg | 18 | 2,637,395 | 476,948 | 1 |
84550 | Uric acid level, blood | 5,995 | 2,619,033 | 11,578,630 | 31 |
A0429 | Ambulance service, basic life support, emergency transport (bls-emergency) | 7,742 | 2,598,660 | 914,248,770 | 1,252 |
73030 | X-ray of shoulder, minimum of 2 views | 34,654 | 2,588,028 | 41,533,486 | 90 |
82746 | Folic acid level, serum | 5,438 | 2,560,679 | 36,849,296 | 86 |
J2469 | Injection, palonosetron hcl, 25 mcg | 2,612 | 2,556,985 | 1,813,652 | 55 |
99497 | Advance care planning, first 30 minutes | 29,529 | 2,539,170 | 156,798,979 | 185 |
85610 | Blood test, clotting time | 7,719 | 2,529,787 | 10,605,081 | 29 |
J0588 | Injection, incobotulinumtoxin a, 1 unit | 256 | 2,512,769 | 10,139,941 | 12 |
G0444 | Annual depression screening, 5 to 15 minutes | 27,976 | 2,511,578 | 44,699,861 | 41 |
99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 6,982 | 2,500,830 | 93,814,831 | 114 |
86003 | Measurement of antibody (ige) to allergic substance, crude allergen extract, each | 284 | 2,483,466 | 12,683,511 | 31 |
71250 | Ct scan of chest without contrast | 21,933 | 2,464,435 | 121,548,831 | 418 |
99205 | New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more | 67,958 | 2,462,628 | 377,969,743 | 562 |
J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 857 | 2,452,956 | 286,096,570 | 299 |
73502 | X-ray of hip, 2-3 views | 33,149 | 2,430,495 | 46,696,753 | 100 |
88342 | Special stained specimen slides to examine tissue, initial procedure | 11,517 | 2,417,798 | 111,797,225 | 193 |
J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 2,341 | 2,389,093 | 530,545 | 2 |
73630 | X-ray of foot, minimum of 3 views | 30,446 | 2,379,415 | 42,146,811 | 82 |
86140 | Measurement c-reactive protein for detection of infection or inflammation | 3,894 | 2,334,614 | 11,833,382 | 56 |
J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 765 | 2,264,496 | 21,867 | 2 |
J2785 | Injection, regadenoson, 0.1 mg | 6,356 | 2,216,463 | 11,810,171 | 141 |
87088 | Bacterial urine culture | 1,895 | 2,200,443 | 17,430,880 | 31 |
95117 | Professional service for multiple injections of allergen | 4,073 | 2,140,086 | 17,904,613 | 36 |
Q9965 | Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml | 284 | 2,137,868 | 2,315,475 | 3 |
82784 | Gammaglobulin (immune system protein) measurement | 1,626 | 2,134,006 | 19,408,426 | 58 |
73562 | X-ray of knee, 3 views | 26,591 | 2,129,460 | 42,250,673 | 103 |
G0471 | Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) | 108 | 2,124,275 | 22,429,905 | 19 |
85652 | Red blood cell sedimentation rate, to detect inflammation, automated | 3,237 | 2,124,132 | 5,617,568 | 30 |
99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | 13,634 | 2,124,063 | 225,517,156 | 293 |
90834 | Psychotherapy, 45 minutes | 10,253 | 2,079,420 | 140,257,392 | 177 |
J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 8,965 | 2,075,988 | 10,777,534 | 20 |
99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 4,522 | 2,066,989 | 63,275,800 | 88 |
99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 6,419 | 2,027,677 | 74,901,155 | 130 |
88185 | Flow cytometry technique for dna or cell analysis, each additional marker | 624 | 2,005,386 | 38,818,547 | 110 |
93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 5,002 | 1,969,899 | 30,756,134 | 93 |
J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 447 | 1,950,771 | 70,990,965 | 182 |
81002 | Urinalysis, manual test | 28,951 | 1,948,017 | 6,609,748 | 15 |
J9030 | Bcg live intravesical instillation, 1 mg | 860 | 1,933,786 | 4,268,412 | 8 |
74176 | Ct scan of abdomen and pelvis without contrast | 22,065 | 1,923,949 | 130,710,123 | 556 |
87077 | Bacterial culture for aerobic isolates | 1,961 | 1,916,230 | 15,156,144 | 33 |
51798 | Ultrasound measurement of bladder capacity after voiding | 9,700 | 1,904,122 | 15,808,282 | 71 |
80307 | Testing for presence of drug, by chemistry analyzers | 4,731 | 1,887,956 | 113,859,278 | 211 |
74018 | X-ray of abdomen, 1 view | 21,785 | 1,886,352 | 15,847,798 | 54 |
93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 7,475 | 1,877,558 | 38,294,438 | 106 |
Q5101 | Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram | 80 | 1,869,848 | 470,130 | 2 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.